NCT06651970 2026-02-23Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailureAstraZenecaPhase 4 Recruiting60 enrolled
NCT06220032 2026-01-05HO170DLBCLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3 Recruiting324 enrolled